Brief: Glaukos Announces Positive Three-Year Epioxa® Results Demonstrating Durable Clinical Outcomes In Keratoconus
07/10/2026 21:14
BRIEF-Glaukos Announces Positive Three-Year Epioxa® Results Demonstrating Durable Clinical Outcomes In Keratoconus Oct 7 (Reuters) - Glaukos Corporation GKOS.N:
GLAUKOS ANNOUNCES POSITIVE THREE-YEAR EPIOXA® RESULTS DEMONSTRATING DURABLE CLINICAL OUTCOMES IN KERATOCONUS
GLAUKOS CORPORATION - THREE-YEAR FOLLOW-UP SHOWS DURABLE EFFICACY AND FAVORABLE SAFETY FOR EPIOXA
GLAUKOS CORPORATION - NO SERIOUS ADVERSE EVENTS OR DISCONTINUATIONS REPORTED IN THREE YEARS AFTER EPIOXA
Source text: ID:nBw7Bwqwwa
Further company coverage: GKOS.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Glaukos
See all newsGlaukos says late-stage eye disease treatment shows lasting benefits after single dose
Brief: Glaukos Announces Positive Three-Year Epioxa® Results Demonstrating Durable Clinical Outcomes In Keratoconus
US RESEARCH ROUNDUP-Boeing, Twilio, WP Carey
U.S. RESEARCH ROUNDUP-Equinix, Meta, S&P Global
Glaukos Corp reports results for the quarter ended June 30 - Earnings Summary